How should patients with a moderate to severe risk of contrast-induced nephropathy (CIN) be monitored before and after contrast administration?

Updated: Dec 18, 2018
  • Author: Anita Basu, MD, FACP; Chief Editor: Vecihi Batuman, MD, FASN  more...
  • Print
Answer

In patients with a moderate to severe risk of CIN, creatinine clearance rates or eGFR should be estimated by either the Modification of Diet in Renal Disease (MDRD) formula or the Cockroft-Gault formula and then measured again 24-48 hours after contrast administration.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!